Australia markets open in 2 hours 35 minutes

Evolution AB (publ) (EVO.ST)

Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
1,207.00+0.50 (+0.04%)
At close: 05:29PM CEST
Currency in SEK

Valuation measures4

Market cap (intra-day) 254.73B
Enterprise value 244.48B
Trailing P/E 20.54
Forward P/E 16.37
PEG ratio (5-yr expected) N/A
Price/sales (ttm)11.95
Price/book (mrq)5.55
Enterprise value/revenue 130.71
Enterprise value/EBITDA 184.67

Trading information

Stock price history

Beta (5Y monthly) 1.04
52-week change 3-6.14%
S&P500 52-week change 322.38%
52-week high 31,469.00
52-week low 3935.00
50-day moving average 31,311.27
200-day moving average 31,199.96

Share statistics

Avg vol (3-month) 3436.01k
Avg vol (10-day) 3503.56k
Shares outstanding 5211.04M
Implied shares outstanding 6215.5M
Float 8183.99M
% held by insiders 116.14%
% held by institutions 152.35%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 431.17
Forward annual dividend yield 42.58%
Trailing annual dividend rate 32.65
Trailing annual dividend yield 30.22%
5-year average dividend yield 41.12
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 429 Apr 2024
Last split factor 25:1
Last split date 323 May 2019

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 58.21%
Operating margin (ttm)62.14%

Management effectiveness

Return on assets (ttm)15.25%
Return on equity (ttm)28.62%

Income statement

Revenue (ttm)1.87B
Revenue per share (ttm)8.78
Quarterly revenue growth (yoy)16.70%
Gross profit (ttm)N/A
EBITDA 1.24B
Net income avi to common (ttm)1.09B
Diluted EPS (ttm)58.78
Quarterly earnings growth (yoy)7.20%

Balance sheet

Total cash (mrq)974.12M
Total cash per share (mrq)4.62
Total debt (mrq)79.73M
Total debt/equity (mrq)2.03%
Current ratio (mrq)2.64
Book value per share (mrq)18.64

Cash flow statement

Operating cash flow (ttm)1.19B
Levered free cash flow (ttm)737.24M